MicroPort^® Urocare, a subsidiary of MicroPort Scientific Corporation (00853.HK), is a leading medical technology company specializing in the development, manufacturing, and commercialization of innovative diagnostic and therapeutic devices for non-vascular interventions. With core competencies in urology, gastrointestinal, and respiratory interventions, MicroPort^® Urocare has established particular expertise in providing comprehensive stone management solutions.

Headquartered in Shanghai's Zhangjiang Hi-Tech Park, MicroPort^® Urocare operates a state-of-the-art R&D center alongside a 3,000-square-meter advanced manufacturing facility in Jiaxing Science City. MicroPort^® Urocare has successfully developed a robust portfolio of competitive urological products and has pioneered a complete, clinically-proven stone management system. Since its inception, MicroPort^® Urocare has maintained a steadfast commitment to innovation, driven by unmet clinical needs and powered by cutting-edge research.

Moving forward, MicroPort^® Urocare remains dedicated to strengthening partnerships with healthcare professionals, fostering collaborative innovation to address critical clinical

challenges. Through continuous technological advancement, the company aims to deliver superior medical solutions that not only meet but exceed clinical demands, ultimately providing accessible, holistic treatment options for non-vascular interventional therapies worldwide.